Sex and female empowerment (SAFE): A randomized trial comparing sexual health interventions for women in treatment for opioid use disorder.
Sex and female empowerment (SAFE): A randomized trial comparing sexual health interventions for women in treatment for opioid use disorder.
复制标题
DOI:
10.1016/j.drugalcdep.2021.108634
复制
发表时间:
2021-04-01
影响因子:
4.2
通讯作者:
O' Grady KE
中科院分区:
文献类型:
--
作者:
Jones HE;Martin CE;Andringa KR;Ellerson RM;Johnson E;Hairston E;O' Grady KE
Unintended pregnancies are prevalent among women with opioid use disorder (OUD). The Sex and Female Empowerment (SAFE) project developed a social-cognitive, theory-driven intervention to increase acceptance of and adherence to contraceptive practices among women receiving medication for OUD (MOUD). This study evaluated the feasibility and acceptability of two SAFE interventions (Face-to-face and Computer-adapted) compared to usual care as well as their efficacy to improve contraception utilization. This pilot randomized trial enrolled 90 heterosexual, non-pregnant, reproductive-age women receiving MOUD. Participants were randomized into either a: SAFE Face-to-face intervention, SAFE Computer-adapted intervention, or usual care (UC) condition (n=30 each) and followed for 6 months. Outcome measures included intervention completion, intervention satisfaction, attendance at a contraception consultation appointment, and long-acting reversible contraceptive (LARC) method receipt. A generalized linear model was used for inferential testing and to estimate least squares means (predicted probabilities for binary outcomes) and their standard errors. Compared to the UC condition, both the SAFE Face-to-face and the SAFE Computer-adapted intervention had higher intervention completion [Means (Standard Errors) = 0.97 (.03) and 0.97 (.03), respectively, vs. 0.53 (.09); ps<.001], higher intervention satisfaction [Ms (SEs) = 3.7 (.11) and 3.8 (.11), respectively, vs. 3.1 (.11); ps<0.001), higher contraception consultation visit attendance [Ms(SEs) = 0.80 (.07) and 0.73 (.08) vs. 0.33 (.09); p<.001], and greater LARC receipt [Ms(SEs) = 0.77 (.08) and 0.73 (.08) vs. 0.23 (.08); p<.001). SAFE appears feasible and efficacious for supporting women in contraception decision-making. Integrating SAFE into women’s comprehensive OUD treatment services holds promise to increase contraceptive decision-making and initiation of a chosen method.
登录
查看更多内容
影响因子:
8
作者:
Larson, Justine J.;Graham, Devon L.;Bada, Henrietta S.
通讯作者:
Bada, Henrietta S.
影响因子:
4.2
作者:
Frazer, Zane;McConnell, Krystle;Jansson, Lauren M.
通讯作者:
Jansson, Lauren M.
影响因子:
3.9
作者:
Heil, Sarah H.;Jones, Hendree E.;Martin, Peter R.
通讯作者:
Martin, Peter R.
影响因子:
5.5
作者:
Klaman, Stacey L.;Turner, Kea;Jones, Hendree E.
通讯作者:
Jones, Hendree E.
影响因子:
2.9
作者:
Matusiewicz, Alexis K.;Melbostad, Heidi S.;Heil, Sarah H.
通讯作者:
Heil, Sarah H.